Fimlab expands utilization of Aiforia’s clinical AI solutions

Fimlab Laboratories expands the use of Aiforia’s AI solutions for breast cancer diagnostics, bringing multi-organ Ki67 biomarker quantification into routine clinical use. Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m....

CAMBRIDGE, UK — April 21, 2026 — Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual...

Using Aiforia Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST Aiforia Technologies Plc has signed...

Proscia announces webinar Inside Concentriq: The Product Behind the Top KLAS Score April 28, 2026 | 11am ET | 45 minutes REGISTER NOW Digital Pathology Built for Real-World...

Next month will be my 30th medical school reunion. Not sure where the past 30 years have gone and can tell you little about what happened during the 4 years of medical school other than what happened in medical school. Clinton’s first term...

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for...